Automazione ed EUCAST. Stefania Stefani Dipartimento di Scienze Biomediche e Biotecnologiche UNICT

Size: px
Start display at page:

Download "Automazione ed EUCAST. Stefania Stefani Dipartimento di Scienze Biomediche e Biotecnologiche UNICT"

Transcription

1 Automazione ed EUCAST Stefania Stefani Dipartimento di Scienze Biomediche e Biotecnologiche UNICT

2 formed in 1996 and reorganised in 2001 Represents all European countries. Determines breakpoints for all antimicrobials with activity against bacteria and fungi. Involves expert groups to determine breakpoints for fastidious bacteria (Neisseria, Helicobacter, Clostridium difficile, Listeria, Mycobacteria). Disk diffusion test since December 2009.

3 EUCAST tasks To harmonise breakpoints for existing antimicrobials, to determined breakpoints for new antimicrobials, to revise breakpoints when needed. To define wild type MIC distributions (and ECOFFs) for all common bacteria and fungi for all antimicrobials To standardise AST methodology across Europe To recommend QA schemes (internal and external) To liaise with national and international organisations involved in antimicrobial resistance To advise European authorities on issues related antimicrobial resistance.

4 Saggi di sensibilità : MIC Il cardine di tutti i saggi di sensibilità (ovviamente dei metodi fenotipici, ma indirettamente anche degli altri) è la MIC. MIC La MIC è alla base della determinazione dei breakpoint. I breakpoint servono per interpretare i saggi di sensibilità.

5 Resistenza microbiologica N. isolati S. aureus BREAKPOINT microbiologico Livello Basso moderato livello Alto livello Classificazione microbiologica Wild-type selvaggi Resistenza microbiologica MIC CIPRO

6 Resistenza batterica: definizione clinica N. isolati S. aureus Definiti in base a: - breakpoint microbiol. - farmacocinetica - efficacia clinica BREAKPOINT microbiol. BREAKPOINT clinici WT Classificazione clinica MIC CIPRO

7 Nessun problema? Il processo di semplificazione voluto dalle agenzie (EUCAST e CLSI) ha soddisfatto pienamente le nostre aspettative?

8 Discrepanze tra sistemi automatici e metodiche di riferimento Glicopeptidi e S.aureus Resistenze ai beta-lattamici, colistine e tigeciclina in Gramneg

9 Glycopeptides EUCAST 4.0/2014 MIC breakpoints (mg/l) CLSI 2010 MIC breakpoints (mg/l) Staphylococcus aureus S >R S I R Vancomycin Teicoplanin Telavancin (MRSA) 1 1 CoNS MIC breakpoints (mg/l) MIC breakpoints (mg/l) Vancomycin Teicoplanin

10 Da CLSI ad EUCAST. maggio 2011

11

12 MRSA EUCAST 2014

13 EUCAST guideline for the detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance Glycopeptide non susceptible S.aureus Importance of detection of resistance Required for antimicrobial susceptibility categorization Infection control Public Health YES YES YES 1) Recommended method for MIC detection 2) Recommended methods for NS (GRSA, GISA and hgisa) detection

14 UN ALTRO ESEMPIO

15

16 Ertapenem, imipenem and meropenem distribution in Klebsiella pneumoniae EUCAST 2014

17 MICs and outcome Type of infection Antibiotic regimen Bacteremia Meropenem +amikacin IMP mg/l MEM mg/l ERT mg/l Ak mg/l CIP mg/l Mechanism of resistance Outcome VIM-1 Death SSTIs IAI Ciprofoxacin +amikacin Cefepime +amikacin VIM-1 Cure VIM-1+SHV12 Relapse, change, cure Bacteremia Ertapenem VIM-1+SHV- 12 Breaktrough bacteremia and death cuti Imipenem VIM-1+TEM-1 Relapse, change, cure cuti Meropenem VIM-1 Relapse, change, death cuti Imipenem +levofloxacin Falcone et al., J Clin Microbiol 2009;47: VIM-1+SHV- 12 Relapse, not changed, cure EU.AB Date of preparation May 2014

18 Meccanismi di resistenza ai carbapenemi Le carbapenemasi sono β-lattamasi che idrolizzano le Modificazioni di permeabilità della membrana penicilline, esterna nella (perdita maggior parte di dei porine) casi le cefalosporine, associati a e iperproduzione in maniera variabile di cefalosporinasi i carbapenemioeesbl i monobattami. Questi ultimi non sono idrolizzati dalle metallo-β- lattamasi Up-regulation dei sistemi di efflusso associati a iperproduzione di cefalosporinasi o ESBL Produzione di carbapenemasi: β-lattamasi inibite dall ac. clavulanico (classe A) Metallo-β-lattamasi (classe B) Oxacillinasi a spettro esteso (classe D)

19 Carbapenemasi nei Gram-negativi KPC in K. pneumoniae and E. coli MBLs (IMP and VIM) in P. aeruginosa MBLs (VIM and NDM) negli Enterobatteri OXA-23/24/58 in Acinetobacter OXA-48 in K. pneumoniae and E. coli

20 December 2013

21

22 Rapid antimicrobial susceptibility testing methods five different ways to accelerate susceptibility testing in clinical diagnostics: 1. bypassing conventional culture by direct detection of the pathogen or resistance mechanism in the primary sample; 2. bypassing plate or broth culture dependent susceptibility testing (secondary culture); 3. avoiding time consuming work steps/methods; 4. increasing the sensitivity to the detection of the infectious agent; that means detecting the infectious agent in earlier disease stages at lower viral or microbial loads; 5. earlier detection of an evolving drug resistance during treatment in spreading less susceptible quasispecies.

23 Molecular Antimicrobial Resistant Detection Methods 1a Nucleic acid amplification 1b DNA hybridization-based based 1c Next generation sequencing NGS

24 Recently developed rapid AST methods. 1. Molecular testing methods: Polymerase chain reaction (qpcr, multiplex-pcr, LAMP) DNA-probe hybridization (microarrays/luminex xmap assays) Next generation sequencing (NGS, WGS) 2. Fluorescence in situ hybridization (FISH): peptide nucleic acid (PNA) Probes 3. Mass spectrometry based methods: mass spectrometric beta-lactamase assays, PCR/electrospray ionization mass spectrometry (PCR/ESI MS), minisequencing.

25 Frickmann H et al BioMed Research Intern

26 1a. Nucleic Acid Amplification Methods. quantitative real-time PCR (qpcr) rapidly and simultaneously identification of multiple pathogens in a clinical specimen and accurately detection of resistance genes within a remarkably shorter time (4 6 hours). most of the available commercial qpcr assays detect the presence : meca/mecc genes, which confer methicillin resistance in S. aureus; vana/vanb genes, which confer glycopeptide resistance; ESβL genes that encode extended-spectrum β-lactamases RIF/INH genes which confer rifampicin/isoniazide in M. tuberculosis affordable, sensitive, specific, user friendly, not space demanding, and deliverable qpcr has found various applications in point-of-care testing (POCT).

27 Roche Molecular Systems Inc. 1.LightCycler MRSA Advanced Test: identify MRSA direct from nasal swabs. 2.LightCycler SeptiFast MecA Test: identify MRSA direct from blood samples. 3.LightCycler VRE Detection Kit (RUO): identify vana, vanb, vanb2/3 in VRE (req. DNA extraction).

28 Becton,Dickinson U.K. Ltd./ Cepheid SmartCycler 1.BD GeneOhm VanR: ID of VRE direct from perianal and/or rectal swabs. 2.BD GeneOhm StaphSR: detection and differentiation of MRSA/SA from blood culture, wound and nasal swabs. 3.BD GeneOhm MRSA: direct detection of MRSA from nasal swab.

29 GeneXpert System Fully integrated and automated sample preparation, RT-PCR and detection. Specimens don t need to be batched. <2 mins hands-on time. Results in <1hr 6 targets per sample. Microfluidic cartridge Total hands-on time < 1 minute

30 1. Xpert MRSA A comprehensive approach to MRSA infection control, capable of detecting strains with all SCCmec types found in both healthcare-acquired and community-acquired MRSA.

31 2. Xpert vana/vanb allows an immediate identification of VRE carriers from non-carriers taken from perianal and rectal swab 3. Xpert MTB/RIF identify Mycobacterium tuberculosis (MTB) DNA and resistance to rifampicin (RIF) by nucleic acid amplification technique. In december 2010, the WHO endorsed the test for use in TB endemic countries

32 4. Xpert Carba-R detects and differentiates the most prevalent carbapenemases (KPC, NDM, VIM, OXA-48 and IMP-1) in 48 minutes

33 1a. Nucleic Acid Amplification Methods. multiplex PCR

34 Unyvero Pneumonia Application (UPA) assay multiplex end-point PCR with amplicon detection by array hybridization developed to rapidly and simultaneously detect from respiratory specimens: 18 bacterial species, Pneumocystis jirovecii and 22 resistance markers (http://www.curetis.com/).

35 Filmarray System The panel includes 19 bacteria, five yeasts, and three antibiotic resistance genes: meca, vana/vanb, and the KPC gene. a closed diagnostic system that combines nucleic acid extraction from clinical specimens, high-order nested multiplex PCR analysis and post-pcr DNA melting curve analysis to identify several pathogens and susceptibility markers directly from positive blood culture bottles in 1 h (CE IVD) marking in June 2013.

36 1b. DNA probe-based hybridisation assays DNA Microarray Technology

37 3. Next Generation Sequencing (NGS).

38 To date costs and scarcely available user-friendly bioinformatics platforms make difficult the use of NGS technologies in diagnostic microbiology. NGS technologies provide high-resolution genotyping in a short time frame of only two to five days. Therefore, NGS/WGS in the microbiological laboratory will be the logical next step for the routine diagnosis of infection and the prediction of antimicrobial susceptibility, potentially replacing traditional cultural approaches on the intermediate or long term.

39 Phenotypic vs. genotypic: advantages Can be performed direct from clinical specimens: - Rapid. - Good for difficult to culture organisms or slow-growers. - May reduce biohazard risk. Potential for automation. Simple yes/no answer - not dependent on S/I/R categories. Sort out ambiguous phenotypic results. Good for resistance mechanisms that encode low-level resistance. Inform epidemiological studies.

40 In conclusion Molecular assays for detection of AMR have yielded a wealth of information. Unlikely to replace, but instead augment, phenotypic susceptibility testing. Commercial kits seem to be promising but thorough evaluation in multicentre studies. Several choices for MRSA, VRE, ESBLs. For new resistance genes and mechanisms reference laboratories are mandatory.

Laboratory Considerations for Use of Cepheid Xpert MTB/RIF Assay

Laboratory Considerations for Use of Cepheid Xpert MTB/RIF Assay Fact sheet: cepheid xpert mtb/rif assay November 2013 Laboratory Considerations for Use of Cepheid Xpert MTB/RIF Assay This document is intended to guide laboratories on integrating the Cepheid Xpert MTB/RIF

More information

Tuberculosis. Rapid diagnostics of. tuberculosis and its resistances. Your benefits with the TB product series from Hain Lifescience

Tuberculosis. Rapid diagnostics of. tuberculosis and its resistances. Your benefits with the TB product series from Hain Lifescience Tuberculosis Rapid diagnostics of tuberculosis and its resistances Our molecular test systems allow for an efficient and subsequent detection of MDR or XDRTB. FluoroType MTB is the innovative test system

More information

The Stewardship Geek Squad. Disclosure. Objectives (Pharmacist Track) Calling the Stewardship Geek Squad: Integrating Information Technology &

The Stewardship Geek Squad. Disclosure. Objectives (Pharmacist Track) Calling the Stewardship Geek Squad: Integrating Information Technology & SCSHP 2014 Annual Meeting The Stewardship Geek Squad Calling the Stewardship Geek Squad: Integrating Information Technology & Antimicrobial Stewardship Julie Ann Justo, PharmD, MS, BCPS, AAHIVP Clinical

More information

Rapid tests for MRSA detection at the hospital admission

Rapid tests for MRSA detection at the hospital admission Rapid tests for MRSA detection at the hospital admission Olivier Denis Reference Laboratory for Staphylococci and MRSA ULB-Hôpital Erasme SYMPOSIUM 12th vember 2009 Prevention strategies for MRSA control

More information

Maximizing the Use of the Advanced Expert System To Improve Patient Care

Maximizing the Use of the Advanced Expert System To Improve Patient Care Maximizing the Use of the Advanced Expert System To Improve Patient Care by Vincent J. LaBombardi, Ph.D. Director of Microbiology Mount Sinai Medical Center - New York, NY Mount Sinai Maximizing the Use

More information

Frequently Asked Questions on Xpert MTB/RIF assay

Frequently Asked Questions on Xpert MTB/RIF assay Frequently Asked Questions on Xpert MTB/RIF assay Contents How does the test work?... 2 How was the Xpert MTB/RIF test developed?... 2 What is the public health significance?... 2 What does it cost?...

More information

Performance Evaluation and Clinical Application of MTB NAAT in Orange County, CA. Minoo Ghajar Orange County Public Health Laboratory

Performance Evaluation and Clinical Application of MTB NAAT in Orange County, CA. Minoo Ghajar Orange County Public Health Laboratory Performance Evaluation and Clinical Application of MTB NAAT in Orange County, CA Minoo Ghajar Orange County Public Health Laboratory TB Case Count and Rate: Orange County, CA and the United States, 2012

More information

Technical FAQs on Hain Genotype MTBDRplus Line Probe Assay

Technical FAQs on Hain Genotype MTBDRplus Line Probe Assay What is the Hain Genotype MTBDRplus and how does it work? The Genotype MTBDRplus test is a WHO-endorsed line-probe assay (LPA) for the rapid detection of Mycobacterium tuberculosis complex (MTB) and mutations

More information

Antimicrobial Resistance and Human Health

Antimicrobial Resistance and Human Health Antimicrobial Resistance and Human Health Dearbháile Morris, Discipline of Bacteriology, School of Medicine, National University of Ireland, Galway The microbial world The is a gene Talk cloud in a The

More information

BD Phoenix Automated Microbiology System

BD Phoenix Automated Microbiology System BD Phoenix Automated Microbiology System Resistance Detection Workflow Efficiency Analysis and Communication BD Diagnostics 7 Loveton Circle Sparks, MD 115-0999 800.638.8663 www.bd.com/ds CHROMagar is

More information

REPORT on the Joint EU-US Workshop. Challenges and Solutions in the Development of New Diagnostic Tests to Combat Antimicrobial Resistance

REPORT on the Joint EU-US Workshop. Challenges and Solutions in the Development of New Diagnostic Tests to Combat Antimicrobial Resistance REPORT on the Joint EU-US Workshop Challenges and Solutions in the Development of New Diagnostic Tests to Combat Antimicrobial Resistance Co-organised by the US National Institutes of Health and the European

More information

How molecular biology is changing the diagnosis of respiratory infections in critically ill patients

How molecular biology is changing the diagnosis of respiratory infections in critically ill patients How molecular biology is changing the diagnosis of respiratory infections in critically ill patients Ricardo Serrano PhD. MD Department of Intensive Care Medicine General University Hospital of Alicante

More information

TEST METHOD VERIFICATION AND VALIDATION

TEST METHOD VERIFICATION AND VALIDATION 1 TEST METHOD VERIFICATION AND VALIDATION SWACM 2014 MICHAEL LOEFFELHOLZ, PH.D., ABMM DEPT. PATHOLOGY UNIV TEXAS MEDICAL BRANCH GALVESTON, TX 2 OBJECTIVES Define validation and verification Describe components

More information

Pitfalls of PCR diagnosis of viral infections

Pitfalls of PCR diagnosis of viral infections Pitfalls of PCR diagnosis of viral infections David Whiley Queensland Paediatric Infectious Diseases Laboratory, QCMRI & SASVRC, Royal Children's Hospital, Brisbane. PCR & viral infections PCR technology

More information

Thermo Scientific Sensititre. Susceptibility and Identification System. Customizable testing solutions. maximum performance

Thermo Scientific Sensititre. Susceptibility and Identification System. Customizable testing solutions. maximum performance Thermo Scientific Sensititre Susceptibility and Identification System Customizable testing solutions maximum performance True MIC results the key to battling resistance The Thermo Scientific Sensititre

More information

HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi

HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara, 2/2011 1 The basis of this HUSRES 2010 report is the HUSLAB/Whonet database 2010, which contains susceptibility data

More information

The 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli 2013. Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M.

The 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli 2013. Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M. The 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli 2013 Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M. Aarestrup The 14TH EURL-AR Proficiency Test Enterococci, Staphylococci

More information

Role of The Pharmaceutical Industry in Responsible Antibiotic Stewardship. Janet Hammond, MD, PhD Global Head Infectious Diseases, Roche pred

Role of The Pharmaceutical Industry in Responsible Antibiotic Stewardship. Janet Hammond, MD, PhD Global Head Infectious Diseases, Roche pred Role of The Pharmaceutical Industry in Responsible Antibiotic Stewardship Janet Hammond, MD, PhD Global Head Infectious Diseases, Roche pred The Problem Safe and effective antibiotics have saved billions

More information

The Antimicrobial Susceptibility Testing Device Manufacturer: Development Process, Timelines, and Challenges

The Antimicrobial Susceptibility Testing Device Manufacturer: Development Process, Timelines, and Challenges The Antimicrobial Susceptibility Testing Device Manufacturer: Development Process, Timelines, and Challenges Sheila Farnham, MT(ASCP) President Susceptibility Testing Manufacturers Association January

More information

MALDI-TOF MS. Learning Objectives. MALDI-TOF MS: a new tool to rapidly assess antibiotic susceptibility. After this presentation, you should

MALDI-TOF MS. Learning Objectives. MALDI-TOF MS: a new tool to rapidly assess antibiotic susceptibility. After this presentation, you should MALDI-TOF MS: a new tool to rapidly assess antibiotic susceptibility Sören Schubert, MD Max von Pettenkofer-Institut Ludwig-Maximilians-University (LMU) Munich, Germany Learning Objectives After this presentation,

More information

Jari Hirvonen Hospital Microbiologist Vaasa Central Hospital Dep. of Microbiology. Italy, Padenghe sul Garda March 2013

Jari Hirvonen Hospital Microbiologist Vaasa Central Hospital Dep. of Microbiology. Italy, Padenghe sul Garda March 2013 Jari Hirvonen Hospital Microbiologist Vaasa Central Hospital Dep. of Microbiology Italy, Padenghe sul Garda March 2013 Vaasa Hospital District (VHD) Locates on the coast in western Finland Population ~170

More information

BD Affirm VPIII. Microbial Identification System

BD Affirm VPIII. Microbial Identification System BD Affirm VPIII Microbial Identification System The Only Diagnostic Test that Differentiates and Identifies 3 Vaginitis Pathogens from a Single Sample, with DNA Certainty. Translating the power and the

More information

FACULTY OF MEDICAL SCIENCE

FACULTY OF MEDICAL SCIENCE Doctor of Philosophy Program in Microbiology FACULTY OF MEDICAL SCIENCE Naresuan University 171 Doctor of Philosophy Program in Microbiology The time is critical now for graduate education and research

More information

Xpert GBS LB & Xpert GBS. A complete GBS testing solution

Xpert GBS LB & Xpert GBS. A complete GBS testing solution Xpert GBS LB Xpert GBS A complete GBS testing solution Xpert GBS LB & Xpert GBS Only molecular system with moderately complex antepartum and intrapartum tests on a single platform A better way. Now nurses,

More information

HUSRES Annual Report 2012 Martti Vaara www.huslab.fi www.intra.hus.fi

HUSRES Annual Report 2012 Martti Vaara www.huslab.fi www.intra.hus.fi HUSRES Annual Report 2012 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2013 1 The basis of this HUSRES 2012 report is the HUSLAB/Whonet database 2012, which contains susceptibility data on

More information

IMA Knowledge June, 2015

IMA Knowledge June, 2015 Tuberculosis is a major public health problem in India. Early diagnosis and complete treatment of TB is the corner-stone of TB prevention and control strategy. India's Revised National TB Control program(rntcp)

More information

Laboratory Techniques for the Diagnosis of TB what s available? Dr. Annette Jepson

Laboratory Techniques for the Diagnosis of TB what s available? Dr. Annette Jepson Laboratory Techniques for the Diagnosis of TB what s available? Dr. Annette Jepson Outline of Topics to be Covered Laboratory processing of sputum samples Culture techniques Molecular diagnostics New developments

More information

Disclosure. Objectives. Guidelines. IDSA/SHEA Guidelines 7/25/2013

Disclosure. Objectives. Guidelines. IDSA/SHEA Guidelines 7/25/2013 47 th Annual Meeting August 2-4, 2013 Orlando, FL The Marriage of Antimicrobial Stewardship and Informatics: Improving Patient Outcomes with Technology Jamie Kisgen, Pharm.D., BCPS Clinical Assistant Professor

More information

Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae

Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae Brief Original Article Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae Fernando Pasteran, Celeste Lucero, Melina Rapoport, Leonor Guerriero,

More information

2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey

2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey 2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey Antibiotic resistance is a global issue that has significant impact in the field of infectious diseases.

More information

Antimicrobial Resistance Surveillance in Abu Dhabi

Antimicrobial Resistance Surveillance in Abu Dhabi Antimicrobial Resistance Surveillance in Abu Dhabi Middle East Infection Prevention Summit 4 June 2015, Conrad Hotel, Dubai, UAE Dr. med. Jens Thomsen MPH Environmental Health Section Occupational and

More information

ANTIBIOTIC RESISTANCE. LauraLe Dyner MD Pediatric Infectious Disease Fellow June 2009

ANTIBIOTIC RESISTANCE. LauraLe Dyner MD Pediatric Infectious Disease Fellow June 2009 ANTIBIOTIC RESISTANCE LauraLe Dyner MD Pediatric Infectious Disease Fellow June 2009 Antibiotic Resistance Relative or complete lack of effect of an antimicrobial agent An organism is able to grow in readily

More information

Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852

Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852 December 18, 2012 Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852 Re: Comments on Docket No. FDA 2012 N 1037; Establishing a List of

More information

RealStar HBV PCR Kit 1.0 11/2012

RealStar HBV PCR Kit 1.0 11/2012 RealStar HBV PCR Kit 1.0 11/2012 RealStar HBV PCR Kit 1.0 For research use only! (RUO) Product No.: 201003 96 rxns INS-201000-GB-02 Store at -25 C... -15 C November 2012 altona Diagnostics GmbH Mörkenstraße

More information

European Centre for Disease Prevention and Control. Updated. Public Health Microbiology Strategy. Work Plan 2012-2016 1,2

European Centre for Disease Prevention and Control. Updated. Public Health Microbiology Strategy. Work Plan 2012-2016 1,2 European Centre for Disease Prevention and Control Updated Public Health Microbiology Strategy & Work Plan 2012-2016 1,2 1 Approved by ECDC Management Board (MB 23; 9 th -10 th November, 2011) and Advisory

More information

Short Report: Failure of Burkholderia pseudomallei to Grow in an Automated Blood Culture System

Short Report: Failure of Burkholderia pseudomallei to Grow in an Automated Blood Culture System Accepted for Publication, Published online October 13, 2014; doi:10.4269/ajtmh.14-0018. The latest version is at http://ajtmh.org/cgi/doi/10.4269/ajtmh.14-0018 In order to provide our readers with timely

More information

Essentials of Real Time PCR. About Sequence Detection Chemistries

Essentials of Real Time PCR. About Sequence Detection Chemistries Essentials of Real Time PCR About Real-Time PCR Assays Real-time Polymerase Chain Reaction (PCR) is the ability to monitor the progress of the PCR as it occurs (i.e., in real time). Data is therefore collected

More information

Updated ECDC Public Health Microbiology Strategy and Work Plan 2012-2016

Updated ECDC Public Health Microbiology Strategy and Work Plan 2012-2016 Updated ECDC Public Health Microbiology Strategy and Work Plan 2012-2016 Marc Struelens Microbiology Coordination Section, Resource Management and Coordination Unit Ole Heuer Surveillance Section, Surveillance

More information

POLYMERASE CHAIN REACTION (PCR) TECHNOLOGIES AND GLOBAL MARKETS

POLYMERASE CHAIN REACTION (PCR) TECHNOLOGIES AND GLOBAL MARKETS POLYMERASE CHAIN REACTION (PCR) TECHNOLOGIES AND GLOBAL MARKETS BIO087C August 2016 Shalini Shahani Dewan Project Analyst ISBN: 1-62296-333-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481

More information

Introduction To Real Time Quantitative PCR (qpcr)

Introduction To Real Time Quantitative PCR (qpcr) Introduction To Real Time Quantitative PCR (qpcr) SABiosciences, A QIAGEN Company www.sabiosciences.com The Seminar Topics The advantages of qpcr versus conventional PCR Work flow & applications Factors

More information

HUSRES Annual Report 2015

HUSRES Annual Report 2015 HUSRES Annual Report 2015 1 This report is based on the HUSLAB/Whonet database 2015, which contains data on more than 190.000 microbes. EUCAST 2015 clinical breakpoints have mainly been used. The doses

More information

Advances in Laboratory TB Diagnosis

Advances in Laboratory TB Diagnosis Advances in Laboratory TB Diagnosis Adam J. Caulfield, Ph.D. Columbus, OH September 29, 2015 2014 MFMER slide-1 Disclosures None 2014 MFMER slide-2 Learning Objectives How mycobacteria are grown and identified

More information

Metagenomics revisits the one pathogen/one disease postulates and translate the One Health concept into action

Metagenomics revisits the one pathogen/one disease postulates and translate the One Health concept into action Les Rencontres de L INRA Metagenomics revisits the one pathogen/one disease postulates and translate the One Health concept into action E Albina (CIRAD) / S Guyomard(Institut Pasteur) Guadeloupe The era

More information

Introduction to DiversiLab

Introduction to DiversiLab Introduction to DiversiLab Knokke 11 oktober 2011 Dirk Jansen Application Specialist BioMerieux Benelux 1 Content Introduction DiversiLab Explanation System Libraries Questions 2 - 2006 BBCI Bacterial

More information

TECHNOLOGY PATENTS IN THE (CONTINUED)... 16

TECHNOLOGY PATENTS IN THE (CONTINUED)... 16 CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 SCOPE AND FORMAT... 1 METHODOLOGY AND INFORMATION SOURCES... 2 INTENDED AUDIENCE... 2 ANALYST CREDENTIALS...

More information

Antibiotic resistance does it matter in paediatric clinical practice? Jette Bangsborg Department of Clinical Microbiology Herlev Hospital

Antibiotic resistance does it matter in paediatric clinical practice? Jette Bangsborg Department of Clinical Microbiology Herlev Hospital Antibiotic resistance does it matter in paediatric clinical practice? Jette Bangsborg Department of Clinical Microbiology Herlev Hospital Background The Department of Clinical Microbiology at Herlev Hospital

More information

THE BASICS OF PK/PD WITH REGARDS TO BREAKPOINTS. Romney Humphries UCLA Clinical Microbiology

THE BASICS OF PK/PD WITH REGARDS TO BREAKPOINTS. Romney Humphries UCLA Clinical Microbiology THE BASICS OF PK/PD WITH REGARDS TO BREAKPOINTS Romney Humphries UCLA Clinical Microbiology WHAT WE HOPE TO GET FROM A BREAKPOINT Breakpoint Ideal Predict clinical outcome Detect resistance mechanisms

More information

Real-Time PCR Vs. Traditional PCR

Real-Time PCR Vs. Traditional PCR Real-Time PCR Vs. Traditional PCR Description This tutorial will discuss the evolution of traditional PCR methods towards the use of Real-Time chemistry and instrumentation for accurate quantitation. Objectives

More information

Overview of Tuberculosis Epidemiology, Transmission, Clinical Presentation, and Treatment

Overview of Tuberculosis Epidemiology, Transmission, Clinical Presentation, and Treatment Overview of Tuberculosis Epidemiology, Transmission, Clinical Presentation, and Treatment Tuberculosis Airborne disease caused by the bacterium Mycobacterium tuberculosis (M. tb) M. tb complex (MTBC) includes

More information

The ABC s of ESBL for Infection Control Nurses: -Extended-Spectrum Beta-Lactamases-

The ABC s of ESBL for Infection Control Nurses: -Extended-Spectrum Beta-Lactamases- The ABC s of ESBL for Infection Control Nurses: -Extended-Spectrum Beta-Lactamases- Gonzalo Bearman MD, MPH Assistant Professor of Internal Medicine and Public Health Divisions of Quality Health Care &

More information

Quarterly cash flow and activities report 30 June 2015

Quarterly cash flow and activities report 30 June 2015 Quarterly cash flow and activities report 30 June 2015 Genetic Signatures (ASX: GSS) is pleased to report on its activities for the quarter ended 30 June 2015. Highlights: Continued growth in sales of

More information

Ampicillin and Vancomycin Resistant E. faecium PNA FISH. Enterococcus sp.

Ampicillin and Vancomycin Resistant E. faecium PNA FISH. Enterococcus sp. Enterococcus sp. 90 Min. Identification of E. faecalis, E. faecium and Other Enterococci from Positive Blood Cultures Ampicillin and Vancomycin Resistant E. faecium PNA FISH identified E. faecium a median

More information

Nucleic Acid Amplification Life Science Dashboard Series 3

Nucleic Acid Amplification Life Science Dashboard Series 3 Brochure More information from http://www.researchandmarkets.com/reports/1937244/ Nucleic Acid Amplification Life Science Dashboard Series 3 Description: Nucleic acid amplification is one of the most commonly

More information

Micromyx. Micromyx. A Microbiology Services Company. Lab Services Research - Consulting -

Micromyx. Micromyx. A Microbiology Services Company. Lab Services Research - Consulting - A Microbiology Services Company Lab Services Research - Consulting - Regulatory Company description is a microbiology services company specializing in antiinfective discovery and development for the pharmaceutical,

More information

HUSRES Annual Report 2008 Martti Vaara. www.huslab.fi www.intra.hus.fi

HUSRES Annual Report 2008 Martti Vaara. www.huslab.fi www.intra.hus.fi HUSRES Annual Report 2008 Martti Vaara www.huslab.fi www.intra.hus.fi The basis of this HUSRES 2008 report is the HUSLAB/Whonet database 2008, which contains susceptibility data on about 180.000 bacteria

More information

Dr. Khalil Yusef Rashid Abujheisha.

Dr. Khalil Yusef Rashid Abujheisha. Dr. Khalil Yusef Rashid Abujheisha. Place and date of birth: Hebron/Palestine, 08/08/1971. Nationality: Palestinian. Marital status: Married (5 kids). Telephone number: Saudia Arabia: 00966550903341 Email:

More information

Antimicrobial drug resistance among poultry isolates from broilers on antimicrobials

Antimicrobial drug resistance among poultry isolates from broilers on antimicrobials Antimicrobial drug resistance among poultry isolates from broilers on antimicrobials Dr. J. W Oguttu a,b Prof. C. M. Veary b Dr. J. A. Picard b a b University of South Africa Faculty of Veterinary Science,

More information

Antibiotic susceptibility

Antibiotic susceptibility Antibiotic susceptibility Antibiotic: natural chemicals produced by bacteria, fungi, actinomycetes, plants or animals, and either inhibits or kills other microbes and/or cells Chemotherapeutic agent: A

More information

An Update: Carbapenem resistant Enterobacteriaceae (CRE) Lynn Ramirez Avila Clinical Epidemiology and Infection Prevention May 26, 2014

An Update: Carbapenem resistant Enterobacteriaceae (CRE) Lynn Ramirez Avila Clinical Epidemiology and Infection Prevention May 26, 2014 An Update: Carbapenem resistant Enterobacteriaceae (CRE) Lynn Ramirez Avila Clinical Epidemiology and Infection Prevention May 26, 2014 Outline Definitions Epidemiology Outcomes Treatment Prevention CRE

More information

Point-of-Care Molecular Diagnostics: The Future

Point-of-Care Molecular Diagnostics: The Future Point-of-Care Molecular Diagnostics: The Future Frederick L. Kiechle, MD, PhD Medical Director, Clinical Pathology Memorial Healthcare System Pathology Consultants of South Broward, LLP Hollywood, FL 33021

More information

LightCycler 480 Real-Time PCR System: Innovative Solutions for High-Throughput PCR

LightCycler 480 Real-Time PCR System: Innovative Solutions for High-Throughput PCR LightCycler 480 Real-Time PCR System: Innovative Solutions for High-Throughput PCR Options for High-Throughput PCR Robotics Automated plate loading Ready-to-use and stable reagents Increasing throughput

More information

19th Swiss TB Symposium Münchenwiler, 25.03.2010

19th Swiss TB Symposium Münchenwiler, 25.03.2010 19 th SWISS TUBERCULOSIS SYMPOSIUM Update on culture and identification Münchenwiler, 25.03.2010 Dr. Thomas Bodmer, M.D. Institute for Infectious Diseases Culture of mycobacteria Cultivation of MTB in

More information

Mycobacteria: Part 2

Mycobacteria: Part 2 This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics Welcome to Mayo Medical Laboratories Hot Topics. These presentations provide short discussion

More information

ANTIMICROBIAL RESISTANT ORGANISMS (ARO) SURVEILLANCE

ANTIMICROBIAL RESISTANT ORGANISMS (ARO) SURVEILLANCE Antimicrobial Resistant Organisms (ARO) Surveillance ANTIMICROBIAL RESISTANT ORGANISMS (ARO) SURVEILLANCE SUMMARY REPORT FOR DATA FROM JANUARY 1, 2009 TO DECEMBER 31, 2014 Updated July 2015 Antimicrobial

More information

GLYKOPEPTID- RESISTENS HOS ENTEROKOKKER

GLYKOPEPTID- RESISTENS HOS ENTEROKOKKER GLYKOPEPTID- RESISTENS HOS ENTEROKOKKER KRISTIN HEGSTAD Wirth 1994 Eur J Biochem 222:235-46 ENTEROCOCCI (1) Gram+, normal inhabitants of the gastrointestinal tract (GIT) Arias 2012 Nat Rev Microbiol 16:266-78

More information

HUSRES Annual Report 2013 Martti Vaara www.huslab.fi www.intra.hus.fi

HUSRES Annual Report 2013 Martti Vaara www.huslab.fi www.intra.hus.fi HUSRES Annual Report 2013 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2014 1 The basis of this HUSRES 2013 report is the HUSLAB/Whonet database 2013, which contains susceptibility data on

More information

Global Spread of Carbapenemase- Producing Klebsiella pneumoniae

Global Spread of Carbapenemase- Producing Klebsiella pneumoniae Global Spread of Carbapenemase- Producing Klebsiella pneumoniae These pathogens arose in the mid-1990s and continue to spread, leaving few options for treating infected patients John Quale John Quale is

More information

Recombinant DNA technology (genetic engineering) involves combining genes from different sources into new cells that can express the genes.

Recombinant DNA technology (genetic engineering) involves combining genes from different sources into new cells that can express the genes. Recombinant DNA technology (genetic engineering) involves combining genes from different sources into new cells that can express the genes. Recombinant DNA technology has had-and will havemany important

More information

COLONIZATION AND INFECTION CAUSED BY EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL)- PRODUCING ESCHERICHIA COLI IN NEUTROPENIC CANCER PATIENTS

COLONIZATION AND INFECTION CAUSED BY EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL)- PRODUCING ESCHERICHIA COLI IN NEUTROPENIC CANCER PATIENTS COLONIZATION AND INFECTION CAUSED BY EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL)- PRODUCING ESCHERICHIA COLI IN NEUTROPENIC CANCER PATIENTS Principal investigator: Dr Francesc Gudiol Munté Bellvitge University

More information

REAL-TIME PCR KITS FOR DIAGNOSIS

REAL-TIME PCR KITS FOR DIAGNOSIS REAL-TIME PCR KITS FOR DIAGNOSIS 483 Reproducible, Sensitive and Precise Analysis Real Time PCR (qpcr) has revolutionized biological and medical sciences by providing quantitative detection of specific

More information

HBV Quantitative Real Time PCR Kit

HBV Quantitative Real Time PCR Kit Revision No.: ZJ0002 Issue Date: Aug 7 th, 2008 HBV Quantitative Real Time PCR Kit Cat. No.: HD-0002-01 For Use with LightCycler 1.0/LightCycler2.0/LightCycler480 (Roche) Real Time PCR Systems (Pls ignore

More information

ANTIBIOTIC RESISTANCE THREATS. in the United States, 2013

ANTIBIOTIC RESISTANCE THREATS. in the United States, 2013 ANTIBIOTIC RESISTANCE THREATS in the United States, 2013 TABLE OF CONTENTS Foreword... 5 Executive Summary.... 6 Section 1: The Threat of Antibiotic Resistance... 11 Introduction.... 11 National Summary

More information

Bureau of Laboratory Quality Standards Page 1 of 6

Bureau of Laboratory Quality Standards Page 1 of 6 Biomolecular 1. Plasma HIV (RNA) Reverse Transcriptase PCR 2. Plasma HIV Viral Load (RNA) 3. Plasma HIV-1 Drug Resistance (RNA) - Reverse Transcriptase PCR - Sequencing 2 Genes (Protease 4. and Body Fluid

More information

Verification/Validation of Non- FDA Approved Tests

Verification/Validation of Non- FDA Approved Tests Verification/Validation of Non- FDA Approved Tests Michael Loeffelholz, Ph.D. ABMM Professor, Dept. Pathology Director, Clinical Microbiology Laboratory University of Texas Medical Branch, Galveston 1

More information

Questions & Answers on Antibiotic Susceptibility Testing

Questions & Answers on Antibiotic Susceptibility Testing 03-07 / 002GB99112A / This document is not legally binding. biomérieux S.A. reserves the right to modify specifications without notice / BIOMERIEUX and the blue logo, are used, pending and/or registered

More information

Annex to the Accreditation Certificate D-PL-13372-01-00 according to DIN EN ISO/IEC 17025:2005

Annex to the Accreditation Certificate D-PL-13372-01-00 according to DIN EN ISO/IEC 17025:2005 Deutsche Akkreditierungsstelle GmbH German Accreditation Body Annex to the Accreditation Certificate D-PL-13372-01-00 according to DIN EN ISO/IEC 17025:2005 Period of validity: 26.03.2012 to 25.03.2017

More information

Management of Extended Spectrum Beta- Lactamase (ESBL) Producing Enterobacteriaceae in health care settings

Management of Extended Spectrum Beta- Lactamase (ESBL) Producing Enterobacteriaceae in health care settings Management of Extended Spectrum Beta- Lactamase (ESBL) Producing Enterobacteriaceae in health care settings Dr. Mary Vearncombe PIDAC-IPC February 2012 Objectives: To provide an overview of the RP/AP Annex

More information

Guidelines for Antimicrobial Stewardship in Hospitals in Ireland. A Strategy for the Control of Antimicrobial Resistance in Ireland

Guidelines for Antimicrobial Stewardship in Hospitals in Ireland. A Strategy for the Control of Antimicrobial Resistance in Ireland A Strategy for the Control of Antimicrobial Resistance in Ireland Guidelines for Antimicrobial Stewardship in Hospitals in Ireland Hospital Antimicrobial Stewardship Working Group Guidelines for Antimicrobial

More information

Recommendations for the control of Multi-drug resistant Gram-negatives: carbapenem resistant Enterobacteriaceae. November 2013

Recommendations for the control of Multi-drug resistant Gram-negatives: carbapenem resistant Enterobacteriaceae. November 2013 Recommendations for the control of Multi-drug resistant Gram-negatives: carbapenem resistant Enterobacteriaceae November 2013 ISBN: Print: 978-1-921983-55-9 Electronic: 978-1-921983-56-6 Suggested citation:

More information

Identification of the VTEC serogroups mainly associated with human infections by conventional PCR amplification of O-associated genes

Identification of the VTEC serogroups mainly associated with human infections by conventional PCR amplification of O-associated genes Identification of the VTEC serogroups mainly associated with human infections by conventional PCR amplification of O-associated genes 1. Aim and field of application The present method concerns the identification

More information

ANTIBIOTICS IN SEPSIS

ANTIBIOTICS IN SEPSIS ANTIBIOTICS IN SEPSIS Jennifer Curello, PharmD, BCPS Clinical Pharmacist, Infectious Diseases Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center October 27, 2014 The power of antibiotics

More information

Best Practices for Maintaining Quality in Molecular Diagnostics Gyorgy Abel, MD, PhD

Best Practices for Maintaining Quality in Molecular Diagnostics Gyorgy Abel, MD, PhD Best Practices for Maintaining Quality in Molecular Diagnostics Gyorgy Abel, MD, PhD Director, Clinical Chemistry Molecular Diagnostics / Immunology Department of Laboratory Medicine Lahey Clinic Medical

More information

Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7

Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7 Volume 12 December 2011 Table of Contents Summary of Test Changes... 3 Test Changes... 6 Human Anti-Mouse AB (HAMA), ELISA... 6 Hepatitis E Antibody (IgG, IgM)... 6 Hepatitis E Antibody (IgG)... 6 Hepatitis

More information

Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs

Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs Journal of Antimicrobial Chemotherapy (2002) 50, 1045 1049 DOI: 10.1093/jac/dkf211 Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both

More information

QUICK CELL CAPTURE AND CHARACTERIZATION GUIDE FOR CELLSEARCH CUSTOMERS

QUICK CELL CAPTURE AND CHARACTERIZATION GUIDE FOR CELLSEARCH CUSTOMERS QUICK CELL CAPTURE AND CHARACTERIZATION GUIDE FOR CELLSEARCH CUSTOMERS CellSave EDTA Blood sample Rare cell capture Enumeration Single protein marker Cell capture for molecular characterization CELLSEARCH

More information

Molecular Diagnostics for TB: January 21, 2015 What are NAATS and How Do You Use Them?

Molecular Diagnostics for TB: January 21, 2015 What are NAATS and How Do You Use Them? Molecular Diagnostics for Tuberculosis: What are NAATs and How Do You Use Them? Gisela Schecter, MD, MPH California Department of Public Health January 21, 2015 Outline What are NAATs? What is the added

More information

Multi-drug Resistant Organisms

Multi-drug Resistant Organisms TASMANIAN INFECTION PREVENTION AND CONTROL UNIT Multi-drug Resistant Organisms Surveillance Module for rural hospitals and non-acute settings. Version 1 Department of Health and Human Services Multi-drug

More information

Reliable PCR Components for Molecular Diagnostic Assays

Reliable PCR Components for Molecular Diagnostic Assays Reliable PCR Components for Molecular Diagnostic Assays Terri McDonnell, MBA, PMP Senior Program Manager, Molecular Diagnostics March 2014 In this webinar we will: Discuss requirements for amplification

More information

(SAMPLE COPY, NOT FOR RESALE)

(SAMPLE COPY, NOT FOR RESALE) TriMark Publications May 2016 Volume: TMRMDIDT16-0501 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers

More information

GeneXpert Technology. Indira Soundiram 2012

GeneXpert Technology. Indira Soundiram 2012 GeneXpert Technology Indira Soundiram 2012 A Better Way to Platform Design GeneXpert Infinity-48 GeneXpert Module GX-I GX-II GX-IV GX-XVI 2 Defining Molecular Diagnostics Any Test Any Time Any Sample Any

More information

Chromatic Chromogenic culture media for microbial identification and for the screening of antimicrobial resistance mechanisms

Chromatic Chromogenic culture media for microbial identification and for the screening of antimicrobial resistance mechanisms Liofilchem Chromatic Chromogenic culture media for microbial identification and for the screening of antimicrobial resistance mechanisms www.liofilchem.it Liofilchem s.r.l. Zona Industriale 64026 Roseto

More information

Canadian Public Health Laboratory Network. Core Functions of Canadian Public Health Laboratories

Canadian Public Health Laboratory Network. Core Functions of Canadian Public Health Laboratories Canadian Public Health Laboratory Network Core Functions of Canadian Public Health Laboratories Canadian Public Health Laboratory Network The CPHLN Core Functions of Canadian Public Health Laboratories

More information

SURVEILLANCE REPORT. Antimicrobial resistance surveillance in Europe. www.ecdc.europa.eu

SURVEILLANCE REPORT. Antimicrobial resistance surveillance in Europe. www.ecdc.europa.eu SURVEILLANCE REPORT Antimicrobial resistance surveillance in Europe 2010 www.ecdc.europa.eu Antimicrobial resistance surveillance in Europe Annual report of the European Antimicrobial Resistance Surveillance

More information

Core Functions and Capabilities. Laboratory Services

Core Functions and Capabilities. Laboratory Services Core Functions and Capabilities British Columbia Centre for Disease Control Laboratory Services Understanding the role and value of British Columbia s public health laboratory in protecting our community

More information

ANTIBIOTIC RESISTANT ORGANISMS SURVEILLANCE PROTOCOL FOR ONTARIO HOSPITALS

ANTIBIOTIC RESISTANT ORGANISMS SURVEILLANCE PROTOCOL FOR ONTARIO HOSPITALS ANTIBIOTIC RESISTANT ORGANISMS SURVEILLANCE PROTOCOL FOR ONTARIO HOSPITALS Developed by the Ontario Hospital Association and the Ontario Medical Association Joint Communicable Diseases Surveillance Protocols

More information

107, %, P < 01001

107, %, P < 01001 2002 1 40 1 Chin J Pediatr January 2002 Vol 40 No. 1 45 2 294 1 906 (PCR) (MP) ;307 ;81 (NPS) (RSV) (ADV) 1 906 28 1147 % ;544 107 19167 % P < 01001 A ( GAS) 1816 % 615 % 213 % 210 % 210 % ;34 GAS 26 7615

More information

Solid Organ Transplantation

Solid Organ Transplantation Solid Organ Transplantation Infection Prevention And Control Transplant Atlantic 2011 October 13/2011 Kathy Hart Introduction In the past several years, the drugs that we use, the surgeries themselves,

More information

Expanding our Knowledge about Paediatric Pneumonia. David Murdoch Department of Pathology University of Otago, Christchurch

Expanding our Knowledge about Paediatric Pneumonia. David Murdoch Department of Pathology University of Otago, Christchurch Expanding our Knowledge about Paediatric Pneumonia David Murdoch Department of Pathology University of Otago, Christchurch Outline The global burden of childhood pneumonia The challenges of determining

More information

Drive Process Productivity

Drive Process Productivity Solutions for the Biopharmaceutical Industry Drive Process Productivity Innovative solutions from a proven technology leader Your partner in productivity Whether you are developing a process for a novel

More information

1. Introduction. 2. Problem statement

1. Introduction. 2. Problem statement 1. Introduction 2. Problem statement 2.1. Historical context of AMR 2.2. Latest data, statistics and studies 3. Reflection points 3.1. Antibiotics development 3.2. Workforce Training 3.3. Antibiotics prescription

More information